Actively Recruiting
Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
Led by Ain Shams University · Updated on 2025-05-14
85
Participants Needed
1
Research Sites
85 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to evaluate the added value of non-contrast abbreviated MRI protocol featuring ultra-high B value Diffusion Weighted Imaging to detect, characterize suspicious breast lesions and avoid using contrast.
CONDITIONS
Official Title
Effectiveness of Introducing Ultra-High B-Value Diffusion-Weighted Imaging as a Modified Abbreviated Protocol for Breast Cancer Detection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women with suspicious breast mass classified as BIRADS 4a
- Women at high risk due to positive family history of breast cancer
- Women with suspicious axillary lymph nodes detected by Ultrasound
- Women with dense breasts scheduled for MRI imaging
You will not qualify if you...
- Contraindications to MRI such as pacemaker, cochlear implant, claustrophobia, or ocular implants
- Contraindications to contrast administration including elevated kidney function
- Women who have not undergone reliable Mammogram and Ultrasound
- Women with prior treatment or intervention like biopsy
- Patients who refuse to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Ain Shams University
Cairo, Abbasia, Egypt
Actively Recruiting
Research Team
A
Ahmed Mohamed Aly
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here